請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/31584
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鍾國彪 | |
dc.contributor.author | Chiu-Feng Su | en |
dc.contributor.author | 蘇秋鳳 | zh_TW |
dc.date.accessioned | 2021-06-13T03:15:16Z | - |
dc.date.available | 2006-08-11 | |
dc.date.copyright | 2006-08-11 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-31 | |
dc.identifier.citation | 中文文獻
石崇良(2003):「92年病人安全現況調查問卷結果」http://www.tjcha.org.tw/ 吳芝儀,李奉儒譯(1995):質的評鑑與研究,台北,桂冠 林麗英(1998):護理人員對化學治療知識與態度的探討,榮總護理第十五卷第一期 1998 張秉宜(2005):護理給藥錯誤之研究,台灣大學醫療機構管理研究所碩士論文 陳瑞瑩(2005): 藥師調劑錯誤之研究,台灣大學醫療機構管理研究所碩士論文 莊美華(2003):醫療院所電腦處方開立疏失探討. 慈濟醫學2003,15,N0.5 葛文德著,廖月娟譯(2003):一位外科醫師的修煉 天下文化 羅文帥(2001):腫瘤化學治療藥品電腦開方失誤之探討,台灣醫學2001年5卷3期,277-289 簡春安,鄒平儀(1998):社會工作與質性研究於社會工作研究 醫策會網站之病人安全專區 http://www.tjcha.org.tw/ 英文文獻 ASHP(1993) Guidelines on preventing medication errors in hospitals, Am J Hosp pharm. 50:305-14 ASHP (2002) Guidelines on Preventing Medication Errors with Antineoplastic Agents. Am J Health-Syst Pharm. 59;1648-68 Attilio RM. (1996) Caring enough to understand:the road to oncology medication error prevention. Hosp pharm 1996;31:17-26 Bain PG, (1991) Intrathecal vinctistine: a fatal chemotherapeutic error with devastating central nervous system effects J Neurol;238:230-4 Barry R. (2000) A continuous-improvement approach for reducing the number of chemotherapy -related medication errors.Am J Health-Syst Pharm-Vol 57 Dec 15, suppl 4 Bates DE, (1995) Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA;274:29-34 Bethesda, (2003) Pharmacy-nursing shared vision for safe medication use in hospitals: Executive session summary. Am J Health-Syst Pharm. 60:1046-52 Bonnabry P. (2006) Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. Internation journal for Quality in Health Care; Volume 18, Number 1:pp.9-16 Bourret JA. (1996) Medication use review process and information systems utilized for oncology chemotherapy quality improvement. Pharmacy Practice Management Quarterly. 16(1):1-17, Apr Bryman (1992), Quality and Quantity in Social Research Cathy Tokarski, (2005) Computer order entry systems can increase medication errors. JAMA.;1197-1203, 1261-1263 Cohen, (1996) Preventing medication errors in cancer chemotherapy. American Journal of Health-System Pharmacy. 53(7):737-46, Apr 1 Cohen, (2003) Getting to the root of medication errors: Survey results. Nursing, 33(9),36-46 Coles G. (2005) Using failure mode effects and criticality analysis for high-risk processes at three community hospitals. Joint Commission Journal on Quality & Patient Safety. 31(3):132-40, Mar. Darryl S. (2004) American Journal of Health-System pharmacy New JCAHO Medication Management Standards David M. (2003) Reducing medication errors and increasing patient safety: case studies in clinical pharmacology, The Journal of Clinical Pharmacology, 43:768-783 Dinning C(2005), Chemotherapy error reduction: A multidisciplinary approach to create templated order sets. Journal of pediatric oncology nursing.22(1):20-30, Jan-Feb Fields M (2005). Intravenous medication safety system averts high-risk medication errors and provides actionable data. Nursing Administration Quarterly. 29(1):78-87, Jan-Mar Fischer DS, (1996) Improving the cancer chemotherapy use process. J Clin Oncol;14:3148-55 Forster AJ(2004) , Pharmacist surveillance of adverse drug events, American journal of health-system pharmacy.61(14)1466-72, Jul 15 Gavin N. (2004) Cytotoxic chemotherapy in the home: a study of community nurses' attitudes and concerns. British Journal of Community Nursing. 9(1):18-24, Jan Glaser(1978).Theoretical sensitivity Guba, E.G. Lincoln, Y.S.(1985)Naturalistic Inquiry Husch M (2005). Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Quality & Safety in Health care. 14(2):80-6, Apr Hutcherson (1997), Preventing errors with antineoplastic agents: A pharmacist's approach. Hospital Pharmacy. 32(2):194-202,209, February Institute of Medicine (1999) To Err is Human: Building a safer health system. Washington, DC: National Academy Press, Jane S (2000) Report on the national summit on medical errors and patient safety research. Medscape Pharmacists 1(2) Kuuppelomaki M. (1997) Attitude of cancer patients, their relatives, nurses and doctors to active euthanasiaHoitotiede. 9(4):186-93, Leape. (1995) Systems analysis of adverse drug events. JAMA; 274(1):35-43 Leape. (1991) The nature of adverse events in houspitalized patients. New Engl J Med; 324: 377-384. Lehmann CU, (2005) Prevention of medication errors. Clinics in Perinatology. 32(1):107-23, VII, Mar Lesar TS. (1997) Factors related to errors in medication prescribing. JAMA; 277: 312-317. Lisby M. (2005) Errors in the medication process: frequency, type, and potention clinical consequences. International Journal for Quality in Health Care. 17(1):15-22, Feb Martin F. (2004) Prevention of preparation errors of cytotoxic drugs in centralized units: from epidemiology to quality assurance. Bulletin du Cancer. 91(12):972-6, Dec. Miller & Crabtree (1992) Primary care Research: A Multimethod Typology and Qualitative Road Map Morimoto T. (2004) Adverse drug events and medication errors: detection and classification methods. [Journal Article] Quality & Safety in Health Care.13(4):306-14, 2004 Aug Muller T (2003) Typical medication errors in oncology:Analysis and prevention strategies. Onkologie.26(6):539-44, Dec. Munhall (1989), Qualitive design Munhall (2001), Nursing research, A qualitative perspective(p161~179) Mutter M. (2003) One Hospital’s Journey toward Reducing Medication Errors.Joint Commission Journal on Quality and safety. 29(6):279-288 Myhre SL. (1996) Cancer knowledge and perceptions among Chinese factory workers: implications for cancer control and prevention. Cancer Detection & Prevention. 20(3):223-33, Nebeker JR, (2005) High rates of adverse drug events in a highly computerized hospital. Archives of Internal Medicine. 165(10):1111-6, May 23 Opfer KB. (1999) A chemotherapy standard order form: preventing errors. Oncology Nursing Forum. 26(1):123-8, Jan-Feb Pamela stetina, (2005) Managing Medication Errors - A Qualiaative Study. Medsurg Nursing, June, Vol. 14/No.3: 174-178 Passik SD (2000) A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. Journal of Pain & Symptom Management. 19(4):274-86, Apr Patton, (2002) Qualitative Evaluation and Research Method Pourrat X.(2004) Pharmacy World & Science.26(2):64-5, Apr Roush W. (1995) Dana-Farber death sends a warning to research hospitals. Science 269:295-6 Schulmeister L. (2004) Preventing vincristine sulfate medication error. Oncol Nurs Forum Sep 17;31(5):E90-8 Schulmeister L. (1999) Chemotherapy medication errors: descriptions, severity, and contributing factors. Oncology Nursing Forum. 26(6):1033-42, Jul Schulmeister L (1997) Preventing chemotherapy dose and schedule errors. Clinical Journal of Oncology Nursing. 1(3):79-85, Jul. Schulmeister L. (2005) Ten simple strategies to prevent chemotherapy errors. Clinical Journal of Oncology Nursing. 9(2):201-5, Apr. Strauss, A.& Cobin, J. (1990) Basics of Qualitative Research; Grounded Theory Procedure and Techniques.Newsbury Thomas EJ. (2000)Incidence and types of adverse events and negligent care in Utah and Colorado.Med Care ; 38: 261-271 Vadaparampil ST (2005) Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility American Journal of Medical Genetics. Part A. 135(1):41-6, May 15. Vuelta Arce M (2005) Assessing quality in the process of using hazardous drugs-prescription and preparation .Farmacia Hospitalaria. 29(2):119-225, Mar Wayne adachi. (2005) Use of failure mode and effects analysis in improving the safety of IV drug administration. Am J Health-Syst Pharm. Vol 62, May Whitmore CK (1985) Chemotherapy administration precheck verification. Hospital Pharmacy. 20(10):751-4, Oct. Womwer, (2002) Multidisciplinary system approaches to chemotherapy safety” Rebuilding processes and Holding the gains. J Clin Oncol. Volume 20(24) December 15, 4705-4712 Woodhouse S. (2004) To err is human: improving patient safety through failure mode and effect analysis. Clinical Leadership & Management review. 18(1):32-6, Jan-Feb | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/31584 | - |
dc.description.abstract | 化學治療藥物,若是用藥過程中因不適當的處方、調配錯誤或給藥錯誤,產生用藥錯誤的醫療疏失,例如不適當的劑量過高,可能會破壞病患的治療結果,或是產生主要器官衰竭甚至於死亡。在執行高危險的化學治療藥物給藥過程中,不管是在醫師開立處方、轉錄處方,藥師進行藥品調配,或是護理師執行化學治療藥物與點滴輸液投與過程中,都可能造成錯誤。因此本研究的目的是,針對不同專業的醫療人員,及病患與家屬,提供化學治療藥物給藥流程中錯誤的經驗與看法,並探討影響化學治療藥物給藥流程錯誤的因素。研究設計是以質性深度訪談的方式,對象是有實際執行化學藥物治療,包括開處方的醫師四人(兒科二人、血液内科二人)、調配藥物的藥師八人、與執行給藥的護理人員十人(兒科6人、血液內科兩人),以及監控治療的病童家長三人,進行深度訪談。檢視流程中現有的安全防護機制與造成給藥錯誤的原因。研究結果發現,
(一)醫師錯誤的因素:小兒血液科醫師錯誤的原因,以個人疏失、不小心居多,成人血液科以系統因素比較高,包括核對未確實、未使用標準化的療程計畫書、由對處方陌生的住院醫師開立、欠缺一致性標準化的格式、手抄醫囑字跡潦草、口述處方醫囑。 (二)藥師錯誤的因素:針對藥師調配錯誤的部分,主要是系統因素,以核對處方未確實居多,其次是手工作業流程太多,處方量負荷量大與時間的急迫性為主。 (三)護理人員錯誤的因素:護理人員錯誤的原因,小兒科的病房,以個人疏失居多,包括沒有覆核藥品、沒有覆核點滴。成人血液科的病房的錯誤因素,屬於系統因素居多,包括醫囑沒有書寫清楚、醫師態度輕忽、安全防護機制失靈。 (四)對於系統中各個不同流程中的防護機制:認為覆核的流程不能少,標準療程計畫書要設立、流程簡化、減少轉錄的過程等。給藥流程中屬於監督角色的病患,獲取醫療相關資訊的方式,有醫療人員主動提供,以及病患與家屬的主動學習。 依據以上結果,提出幾點建議: (一)機構應設立與匯整標準化的療程計畫書,並且訂定使用的標準化格式。 (二)化學藥物治療的病房應集中與整合,護理人員的訓練更精簡有效率。 (三)病患收住院作化學治療的規範要更明確與確實執行,讓給藥流程中的每一個單位有充裕的時間作業。 (四)對於藥劑單位主要的建議是,人員輪調不宜太頻繁,減少手工作業的部分。 (五)對血液科的醫師建議醫囑與處方應清楚的填寫。對藥劑同仁與護理同仁,給藥流程中的覆核已經非常的完備,需要加強的是確實執行的程度。 (六)對未來研究者的建議:建議未來的研究者針對這個主題,可以嘗試將樣本數擴大至全部的醫學中心及區域級以上的醫院,採取問卷調查與焦點團體同時運用的方法,可以兼顧資料的廣度與深度。 關鍵字:化學治療藥物、處方錯誤、調配錯誤、给藥錯誤、安全防護機制 | zh_TW |
dc.description.abstract | If there is inappropriate prescription, dispensing mistake or administration error in chemotherapy process, for example inappropriate high dose chemotherapy agent, it may spoil therapeutic outcome and result in main organ failure even death. In the process of high- risk chemotherapy agent administration, error may happen in any medication-use process, including physician prescription and transcription, pharmacist dispensing, and nurse administration, fluid supplement.
The goal of this study is to find the experience and viewpoint the factors of medication errors in chemotherapy agent administration process. This is a qualitative study for personal interviews with relevant medical staff. The medical staffs include four physicians (two pediatric physicians, two hematologists), eight pharmacists, ten nurses (six in pediatric ward, two in hematology ward) and three patient families. We investigate safety protection mechanism and medication errors in medication-use process for chemotherapy. The study findings are: (1) Physician errors: pediatric physician has more personal errors including uncertain recheck; hematologist has more systemic errors including non-standardized protocol, unfamiliar resident prescription, and lack of standardized format, scratchy handwriting and oral prescription. (2) Pharmacist errors: most of pharmacist errors are systemic errors, uncertain recheck is the most common error, other errors include too may handwriting procedures, heavy prescription loading and time strain. (3) Nurse errors: in pediatric wad, personal error is main. Errors including uncertain medication and fluid recheck. In hematological ward, most errors belong to systemic factors, including unclear prescription writing, careless attitude, and failure of safety protection mechanism. (4) The safeguards in various medication-use processes in system: recheck is necessary, standardized therapeutic protocol, simplified procedure, and reduction of transcription should be set up. Patient and family suggest medical staff should actively supply relevant medical information, and they themselves should learn knowledge voluntarily. According to above findings, we have some suggestions: (1) Our suggestion to hematologist is the order and prescription should be clear, and suggestion to pharmacy and nurse staff is to enforce the actual execution though recheck is certain. (2) Our suggestion to pharmacy department is to reduce staff redeployment and handwriting work. (3) Organization should set up and accumulate standardized chemotherapy protocol, and order standardized format Chemotherapy treatment ward should be assembled and integrated, and nurse staff training will be more concise and effective (4) In order to give each department in treatment enough time, the rule of inward patient chemotherapy should be clearly and certainly executed. (5) Our suggestion to future researcher is to enlarge the study targets to all medical centers and district hospitals, to combine qualitative and focus group interviews to cover both data depth and width. Key words: chemotherapy agent, prescription error, dispensing error, administration error, safety protection | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T03:15:16Z (GMT). No. of bitstreams: 1 ntu-95-P93843009-1.pdf: 1247254 bytes, checksum: 9a401ef266c87fc475c21f2948fc625b (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 目 錄
誌 謝---------------------------------------------------------------- I 中文摘要---------------------------------------------------------------- II Abstract----------------------------------------------------------------- IV 目 錄---------------------------------------------------------------- VI 圖表目錄---------------------------------------------------------------- VIII 附錄目錄---------------------------------------------------------------- IX 第一章 緒論----------------------------------------------------------- 1 第一節 研究背景與動機---------------------------------------------------- 1 第二節 研究目的------------------------------------------------------------- 5 第二章 文獻探討----------------------------------------------------- 6 第一節 藥物錯誤的類別與原因------------------------------------------- 6 第二節 化學治療藥物給藥錯誤類別與原因---------------------------- 13 第三節 化學治療藥物給藥流程潛在危險性相關文獻---------------- 15 第四節 質性研究方法------------------------------------------------------- 23 第五節 文獻綜合討論------------------------------------------------------- 27 第三章 研究方法----------------------------------------------------- 29 第一節 研究設計----------------------------------------------------------- 29 第二節 研究對象----------------------------------------------------------- 31 第三節 資料收集與分析-------------------------------------------------- 33 第四節 研究的信度和效度考量----------------------------------------- 35 第四章 研究結果----------------------------------------------------- 37 第一節 參與個別訪談人員的基本資料-------------------------------- 37 第二節 研究結果----------------------------------------------------------- 38 第五章 討論----------------------------------------------------------- 77 第一節 流程中錯誤的因素探討----------------------------------------- 77 第二節 流程中的潛在的危險性與安全防護機制-------------------- 83 第三節 流程中可以改善的空間-------------------------------------------- 90 第四節 流程中醫療人員與病童家長的角色與態度-------------------- 91 第五節 研究限制-------------------------------------------------------------- 93 第六章 結論與建議----------------------------------------------------- 94 第一節 結論--------------------------------------------------------------------- 94 第二節 建議--------------------------------------------------------------------- 96 參考文獻------------------------------------------------------------------- 98 中文文獻-------------------------------------------------------------------------- 98 英文文獻-------------------------------------------------------------------------- 98 附錄------------------------------------------------------------------------ 104 圖表目錄 表目錄 表2-1 國內外針對藥物錯誤的研究匯整--------------------------------------- 12 表2-2 化學治療藥物錯誤的類別與因素探討-------------------------------- 14 表2-3 化學治療藥物給藥流程中相關的文獻匯整-------------------------- 21 表3-1 訪談的人數與身份別 ---------------------------------------------------- 32 表4-1 醫師在給藥流程中錯誤因素的意見與避免錯誤的安全防護機制- 61 表4-2 藥師在給藥流程中錯誤因素的意見與避免錯誤的安全防護機制 63 表4-3 護理人員在給藥流程中錯誤因素與避免錯誤的安全防護機制-- 67 表4-4 病患在給藥流程中監督的角色---------------------------------------- 70 表4-5 從給藥流程探討醫師錯誤的原因-------------------------------------- 72 表4-6 從給藥流程探討藥師錯誤的原因-------------------------------------- 73 表4-7 從給藥流程探討護理人員給藥錯誤的原因與改善辦法----------- 74 表4-8 給藥流程中的安全防護機制-------------------------------------------- 75 表4-9 給藥流程中的角色與態度------------------------------------------------ 76 表4-10兒科與血液內科醫師錯誤的因素探討-------------------------------- 76 圖目錄 圖2-1藥物不良事件、潛在性藥物不良事件與藥物錯誤彼此之間的關係 10 圖2-2 化學治療藥物給藥流程檢視圖--------------------------------------- 20 附錄目錄 附錄一醫師訪談大綱--------------------------------------- 104 附錄二藥師訪談大綱--------------------------------------- 106 附錄三護理人員訪談大綱----------------------------------- 108 附錄四病患或病患家屬訪談大綱----------------------------- 110 附錄五醫師訪談內容整理----------------------------------- 112 附錄六藥師訪談內容整理----------------------------------- 125 附錄七護理人員訪談內容整理------------------------------- 135 附錄八病患或病患家屬訪談內容整理------------------------- 150 | |
dc.language.iso | zh-TW | |
dc.title | 化學治療藥物給藥流程中錯誤因素的質性探討
-以某醫學中心為例 | zh_TW |
dc.title | A qualitative study on medication errors in process for providing chemotherapy:An example of a medical center | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳端容,林俊彬 | |
dc.subject.keyword | 化學治療藥物,處方錯誤,調配錯誤,给,藥錯誤,安全防護機制, | zh_TW |
dc.subject.keyword | chemotherapy agent,prescription error,dispensing error,administration error,safety protection, | en |
dc.relation.page | 154 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-08-01 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 醫療機構管理研究所 | zh_TW |
顯示於系所單位: | 健康政策與管理研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 1.22 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。